openPR Logo
Press release

Global Famciclovir Market Top Leading Players with Strategies and Forecast 2028

03-24-2022 12:18 PM CET | Health & Medicine

Press release from: Orion Market Research

The global famciclovir market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Famciclovir is used to herpes zoster generally called shingle (a rash that can occur in people who have had chickenpox in the past). It's also used to treat persons with a healthy immune system who have recurrent herpes virus cold sores or fever blisters. The herpes simplex virus causes cold sores. When this virus enters the body, it can cause cold sore outbreaks. Exposure to the scorching sun, chilly wind, a cold or another sickness, a weakened immune system, shifting hormone levels, or even worry can cause cold sore outbreaks. According to the report published by the National Health Portal in February 2021, Herpes caused by the herpes simplex virus (HSV) or herpes virus hominies, is one of the most common infections of humans across the globe. Further, according to the Hopkins Medicine Organization, around 80% of the total US population is suffering oral herps, which is leading cause for cold sores. Thus, such factors are anticipated to fuel the growth of the market globally.
 
Some major players in the market include Novartis International AG, Mylan N.V., Cipla Ltd., Hikma Pharmaceuticals plc, Teva Pharmaceutical Industries Ltd., among others. Th e market players are serving significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, in order to stay competitive in the market. For instance, in February 2019, Maruho and Asahi Kasei Pharma announce first approval in Japan of an additional dosage and administration for anti-herpes virus agent Famvir tab 250 mg" for the treatment of recurrent herpes simplex (herpes labialis/ herpes genitalis).

(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Famciclovir Market at https://orionmarketreports.com/request-sample/?id=92682&submit=Request+Sample%0D%0A

Market Coverage
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Type
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World

Competitive Landscape- Novartis International AG, Mylan N.V., Cipla Ltd., Hikma Pharmaceuticals plc, Teva Pharmaceutical Industries Ltd., among others.

A full report is available at: https://orionmarketreports.com/global-famciclovir-market/92682/
 
Global Famciclovir Market Report by Segment
By Type
125 mg Tablets
250 mg Tablets
500 mg Tablets

By Application
Cold Sores
Genital Herpes
Shingles

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Famciclovir Market Top Leading Players with Strategies and Forecast 2028 here

News-ID: 2585988 • Views: 233

More Releases from Orion Market Research

Probiotics Supplement Market Trends, Business Overview, Industry Growth and Fore …
The global probiotics supplement market is anticipated to grow at a significant CAGR of 7.2% during the forecast period (2022-2028). The rising consumer awareness for healthcare and fitness with rising disposable income, are likely to drive the market growth. Probiotics enable to maintenance of a healthy balance of gut flora and have been linked to a variety of health advantages, including weight loss, digestive health, and immunological function. The market
Brick Pavers Market Top Leading Players with Strategies and Forecast 2028
Brick Pavers Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Brick Pavers market with a focus on the  market. The report provides key statistics on market of Brick Pavers. It is a valuable source of guidance and direction for companies and individuals interested in Brick Pavers industry. Key Players Belgard Acme Brick Company The Belden Brick Company Wienerberger Pine Hall Brick Redland Brick   By Type General Brick Pavers Wall
Global Performance Monitoring Module Market, Size, Share, Analysis Report & Fore …
The global performance monitoring module market is anticipated to grow at a significant CAGR during the forecast period. The adoption of wireless communication technology in machine condition monitoring, and deployment of automated condition monitoring, and the trend toward predictive maintenance of industrial machinery, are all major factors accelerating the growth of the global performance monitoring module market. Free Sample Copy @ https://www.omrglobal.com/request-sample/performance-monitoring-module-market Performance Monitoring Module (PMM) assists in identifying and resolving
Global ETO Sterilization Equipments Market Analysis By Industry Size, Share, Rev …
ETO sterilization is a low temperature process (typically 37 to 63 °C) that uses Ethylene Oxide gas to lower the level of an infectious agent. It is mainly used for products that cannot withstand the heat of normal autoclave sterilization, such as plastics. ETO is used in medical facilities to sterilize critical (sometimes semi-critical) items that are sensitive to moisture or heat and cannot be sterilized by steam sterilization. (Get 15%

All 5 Releases